title: In vivo low density lipoprotein oxidation relates to coronary reactivity in young men.
abstract: OBJECTIVE
  This study was undertaken to examine the relation of in vivo low density lipoprotein (LDL) oxidation and other lipid risk factors to coronary reactivity in normal subjects.
  
  
  BACKGROUND
  Experimental studies have shown that oxidized LDL (ox-LDL) particles are injurious to the vascular wall by impairing its normal vasodilator function.
  
  
  METHODS
  We used noninvasive positron emission tomographic (PET) imaging with intravenous dipyridamole to measure coronary flow reserve, a marker of coronary endothelial and smooth muscle function, in 30 healthy men (mean [+/-SD] age 34.4 +/- 3.2 years). As a marker of in vivo LDL oxidation, the autoantibody titer against ox-LDL was measured by the enzyme-linked immunosorbent assay method.
  
  
  RESULTS
  Plasma levels of autoantibody titer against ox-LDL were inversely associated with coronary flow reserve (r = -0.42, p = 0.023). High LDL cholesterol levels (above median > 3.0 mmol/liter) were associated with a low coronary flow reserve only in subjects expressing simultaneously high levels of ox-LDL titer (above median). Subjects with simultaneously high levels of LDL cholesterol and ox-LDL titer had lower coronary flow reserve values than subjects in other groups (3.89 vs. > 5.0 in other groups, p = 0.066).
  
  
  CONCLUSIONS
  These data provide evidence for the role of ox-LDL in affecting the coronary reactivity in vivo and support the concept that oxidative modification of LDL particles provides a mechanism by which high LDL concentrations exhibit injurious effects on the coronary vascular bed.
authors.affiliation: Department of Clinical Physiology, University of Turku, Finland. olli.raitakari@utu.fi
authors.forename: O T
authors.initials: OT
authors.lastname: Raitakari
authors.forename: O P
authors.initials: OP
authors.lastname: Pitkänen
authors.forename: T
authors.initials: T
authors.lastname: Lehtimäki
authors.forename: S
authors.initials: S
authors.lastname: Lahdenperä
authors.forename: H
authors.initials: H
authors.lastname: Iida
authors.forename: S
authors.initials: S
authors.lastname: Ylä-Herttuala
authors.forename: J
authors.initials: J
authors.lastname: Luoma
authors.forename: K
authors.initials: K
authors.lastname: Mattila
authors.forename: T
authors.initials: T
authors.lastname: Nikkari
authors.forename: M R
authors.initials: MR
authors.lastname: Taskinen
authors.forename: J S
authors.initials: JS
authors.lastname: Viikari
authors.forename: J
authors.initials: J
authors.lastname: Knuuti
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood; D008078:Cholesterol, LDL / Q000276:immunology / Q000378:metabolism*; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000502:physiology*; D004176:Dipyridamole; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D012016:Reference Values; D014055:Tomography, Emission-Computed / Q000379:methods; D014665:Vasodilator Agents
chemical_list: D001323:Autoantibodies; D008078:Cholesterol, LDL; D014665:Vasodilator Agents; D004176:Dipyridamole